CytoMed (GDTC) 10% Owner Choo Chee Kong Buys 112,000 Shares

What Happened Choo Chee Kong, listed as a 10% owner of CytoMed Therapeutics Ltd (GDTC), purchased 112,000 shares on 2026-05-13 at $1.15 per share for a total of $128,778. The transaction is coded as a purchase (P), which is generally considered more informative for investors than routine insider sales.

Key Details

• Transaction date and price: 2026-05-13 @ $1.15 per share; total value $128,778.
• Form 4 filed: 2026-06-15 (Accession: 0001493152-26-028589). This filing date is later than the typical 2-business-day reporting window for insiders.
• Shares owned after transaction: Not specified in the summary provided — see the full Form 4 for "Amount Owned Following Reported Transaction."
• Footnotes/plans: No 10b5-1 plan, tax-withholding, or other special footnotes were noted in the provided transaction summary.

Context As a 10% owner, Choo is a major shareholder rather than necessarily an executive; purchases by major holders can signal increased conviction but do not guarantee future performance. The late filing reduces how timely this information was for the market — check the full SEC Form 4 for complete ownership details and any additional disclosures.